718 results on '"Ghany, Marc G."'
Search Results
52. Functional cure of hepatitis B requires silencing covalently closed circular and integrated hepatitis B virus DNA
53. HBV transcription and translation persist despite viral suppression in HBV‐HIV co‐infected patients on antiretroviral therapy
54. Hepatitis B RNA and Core-Related Antigen Provide Value Beyond DNA in Evaluating e But Not Surface Antigen Clearance
55. Characteristics of Older Patients With Immunotolerant Chronic Hepatitis B Virus Infection
56. The Hepatitis B Vaccine Protects Re-Exposed Health Care Workers, But Does Not Provide Sterilizing Immunity
57. The liver diseases of lipodystrophy: The long-term effect of leptin treatment
58. Discordance Among Transient Elastography, Aspartate Aminotransferase to Platelet Ratio Index, and Histologic Assessments of Liver Fibrosis in Patients With Chronic Hepatitis C
59. Reply to: “Ultrasensitive HBsAg testing predicts HBsAg seroreversion outcomes: Considerations for new and existing therapies”
60. What the Infectious Disease Physician Needs to Know About Pegylated Interferon and Ribavirin
61. NAM 2017 report: A national plan to eliminate hepatitis B and C in the United States by 2030 and the AASLDʼs response
62. Safety and yield of percutaneous liver biopsy in adults and children with chronic hepatitis B: Results from a prospective, multicenter study.
63. A 25-Year Study of the Clinical and Histologic Outcomes of Hepatitis C Virus Infection and Its Modes of Transmission in a Cohort of Initially Asymptomatic Blood Donors
64. Su1336: TREATMENT INITIATION AND OUTCOMES OF AFRICAN AMERICANS AND NON-AFRICAN AMERICANS WITH CHRONIC HEPATITIS B VIRUS (HBV) INFECTION
65. Acute Viral Hepatitis
66. Hepatitis A, B, D, and E
67. Mo1571 COMPARISON OF PERFORMANCE CHARACTERISTICS OF COMMERCIALLY AVAILABLE ASSAYS FOR HEPATITIS D
68. Mo1570 DEFYING DANGER: ASSESSING OLOROFIM'S IMPACT ON THE LIVER - A CASE REPORT OF SEVERE DILI AND SUCCESSFUL RECHALLENGE
69. 1063 INCIDENCE AND FACTORS ASSOCIATED WITH HEPATITIS B SURFACE ANTIGEN LOSS IN A MULTIETHNIC COHORT OF CHRONIC HEPATITIS B PATIENTS
70. Maintenance Peginterferon Therapy and Other Factors Associated With Hepatocellular Carcinoma in Patients With Advanced Hepatitis C
71. S-Adenosyl Methionine Improves Early Viral Responses and Interferon-Stimulated Gene Induction in Hepatitis C Nonresponders
72. Review article: hepatitis B—current and emerging therapies
73. Acute viral hepatitis
74. Reply to Li, Henry, and Nguyen
75. Letter: systematic review with meta‐analysis on the impact of functional cure on clinical outcomes in patients with chronic hepatitis B—authors' reply
76. Hepatitis E Virus Does Not Contribute to Hepatic Decompensation Among Patients With Advanced Chronic Hepatitis C
77. HBV transcription and translation persist despite viral suppression in HBV‐HIV co‐infected patients on antiretroviral therapy.
78. A prospective cohort study of renal function and bone turnover in adults with hepatitis B virus (HBV)‐HIV co‐infection with high prevalence of tenofovir‐based antiretroviral therapy use.
79. Contributors
80. Complication Rate of Percutaneous Liver Biopsies Among Persons With Advanced Chronic Liver Disease in the HALT-C Trial
81. Hepatitis B Virology for Clinicians
82. Pharmacokinetics and Pharmacodynamics of Peginterferon and Ribavirin: Implications for Clinical Efficacy in the Treatment of Chronic Hepatitis C
83. Ribavirin Improves Early Responses to Peginterferon Through Improved Interferon Signaling
84. Factors That Determine the Development and Progression of Gastroesophageal Varices in Patients With Chronic Hepatitis C
85. Predicting Clinical and Histologic Outcomes Based on Standard Laboratory Tests in Advanced Chronic Hepatitis C
86. Natural Killer Cells Are Polarized Toward Cytotoxicity in Chronic Hepatitis C in an Interferon-Alfa–Dependent Manner
87. Reply
88. Spontaneous Clearance of Drug‐Resistant Chronic Hepatitis C Virus Infection
89. Systematic review with meta‐analysis: the impact of functional cure on clinical outcomes in patients with chronic hepatitis B
90. Evolution of Fatty Liver Disease and Relationship With Lipoproteins and Clinical Outcomes in Hepatitis B/Human Immunodeficiency Virus Coinfection
91. The 2020 Nobel Prize for Medicine or Physiology for the Discovery of Hepatitis C Virus: A Triumph of Curiosity and Persistence
92. Effect of HCV RNA Suppression During Peginterferon Alfa-2a Maintenance Therapy on Clinical Outcomes in the HALT-C Trial
93. Present and Future Therapies of Hepatitis B: From Discovery to Cure
94. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus
95. A Cure for the High Cost of Hepatitis C Virus Treatment
96. Hepatitis A, B, D, AND E
97. 81 - Hepatitis D
98. The Ongoing Debate of Who to Treat for Chronic Hepatitis C Virus
99. Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease
100. Weight-Related Effects on Disease Progression in the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.